Ranger Investment Management, L.P. Catalent, Inc. Transaction History

Ranger Investment Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$45.44 - $74.26 $454 - $742	-10 Reduced 18.52%	44 $2,000
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $1,656 - $2,166	-19 Reduced 26.03%	54 $6,000
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $2,537 - $3,131	25 Added 52.08%	73 $8,000
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $4,294 - $5,268	-50 Reduced 51.02%	48 $5,000
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $1,056 - $1,738	-22 Reduced 18.33%	98 $7,000
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $2,734 - $4,658	74 Added 160.87%	120 $6,000
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $2,164 - $2,605	46 New	46 $3,000

511

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Ranger Investment Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ranger Investment Management, L.P. with notifications on news.